Jones Lang LaSalle Incorporated (JLL) capitalization

Current snapshot

Market Cap
$14.12B
46.4M shares × $304.32 · as of last filing 2026-03-31
Net Worth
$7.31B
Stockholders' equity · 2026-03-31
Enterprise Value
$16.49B
Market cap + debt − cash
Net Debt
$2.38B
Debt $2.81B − Cash $436.2M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $16.26B
FY'24 2024-12-31 $12.24B
FY'23 2023-12-31 $9.12B
FY'22 2022-12-31 $7.86B
FY'21 2021-12-31 $14.02B
FY'20 2020-12-31 $7.76B
FY'19 2019-12-31 $8.56B
FY'19 2018-12-31 $5.81B
FY'19 2017-12-31 $6.81B
FY'14 2014-12-31 $6.79B
FY'13 2013-12-31 $4.61B
FY'12 2012-12-31 $3.76B
FY'11 2011-12-31 $2.72B
FY'10 2010-12-31 $3.70B
FY'10 2009-12-31 $2.33B
FY'10 2008-12-31 $947.5M

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $14.55B
Q4'25 2025-12-31 $15.80B
Q3'25 2025-09-30 $14.42B
Q2'25 2025-06-30 $12.36B
Q1'25 2025-03-31 $11.99B
Q4'24 2024-12-31 $12.00B
Q3'24 2024-09-30 $13.08B
Q2'24 2024-06-30 $9.92B
Q1'24 2024-03-31 $9.42B
Q4'23 2023-12-31 $8.97B
Q3'23 2023-09-30 $6.83B
Q2'23 2023-06-30 $7.53B
Q1'23 2023-03-31 $6.92B
Q4'22 2022-12-31 $7.57B
Q3'22 2022-09-30 $7.35B
Q2'22 2022-06-30 $8.68B
Q1'22 2022-03-31 $12.20B
Q4'21 2021-12-31 $13.47B
Q3'21 2021-09-30 $12.89B
Q2'21 2021-06-30 $10.23B
Q1'21 2021-03-31 $9.34B
Q4'20 2020-12-31 $7.58B
Q3'20 2020-09-30 $5.00B
Q2'20 2020-06-30 $5.40B
Q1'20 2020-03-31 $5.30B
Q4'19 2019-12-31 $8.97B
Q3'19 2019-09-30 $7.25B
Q2'19 2019-06-30 $6.48B
Q1'19 2019-03-31 $7.10B
Q4'19 2018-12-31 $5.77B
Q3'18 2018-09-30 $6.63B
Q2'18 2018-06-30 $7.63B
Q1'18 2018-03-31 $8.02B
Q4'19 2017-12-31 $6.76B
Q3'17 2017-09-30 $5.66B
Q2'17 2017-06-30 $5.72B
Q1'17 2017-03-31 $5.09B
Q1'17 2016-12-31 $4.57B
Q3'16 2016-09-30 $5.19B
Q2'16 2016-06-30 $4.44B
Q1'16 2016-03-31 $5.34B
Q1'16 2015-12-31 $7.20B
Q3'15 2015-09-30 $6.53B
Q2'15 2015-06-30 $7.77B
Q1'15 2015-03-31 $7.73B
Q4'14 2014-12-31 $6.72B
Q3'14 2014-09-30 $5.72B
Q2'14 2014-06-30 $5.72B
Q1'14 2014-03-31 $5.36B
Q4'13 2013-12-31 $4.55B
Q3'13 2013-09-30 $3.93B
Q2'13 2013-06-30 $4.11B
Q1'13 2013-03-31 $4.48B
Q4'12 2012-12-31 $3.70B
Q3'12 2012-09-30 $3.42B
Q2'12 2012-06-30 $3.16B
Q1'12 2012-03-31 $3.72B
Q4'11 2011-12-31 $2.66B
Q3'11 2011-09-30 $2.30B
Q2'11 2011-06-30 $4.19B
Q1'11 2011-03-31 $4.42B
Q4'10 2010-12-31 $3.58B
Q3'10 2010-09-30 $3.80B
Q2'10 2010-06-30 $2.90B
Q1'11 2010-03-31 $3.20B
Q4'10 2009-12-31 $2.53B
Q3'10 2009-09-30 $2.05B
Q2'10 2009-06-30 $1.17B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (JLL CIK 0001037976), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

NKTR

NEKTAR THERAPEUTICS

VVV

VALVOLINE INC.

DYN

Dyne Therapeutics, Inc.